Palavras-chave
Como Citar
Resumo
Introducão: A insuficiência cardíaca (IC) é um problema de saúde pública de primeira ordem, caracterizado por alta mortalidade, hospitalizações frequentes e deterioração da qualidade de vida, com prevalência e incidência que estão aumentando em todo o mundo. A vitamina D é um micronutriente importante para a função óptima de muitos órgãos e tecidos por todo o corpo, incluindo o sistema cardiovascular.
Objetivo: O objetivo deste artigo é revisar a relação entre insuficiência cardíaca e a vitamina D.
Metodologia: Foi realizada uma varredura nas bases de indexação Google Scholar e Scopus. Os artigos referentes a insuficiência cardíaca e vitamina D foram selecionados e analisados quanto a sua qualidade e relevância. Conclusão: Foi sugerido que a deficiência de vitamina D pode ser um fator importante tanto na gênese dos fatores de risco quanto nas doenças cardiovasculares.
Referências
- Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007; 93(9):1137-46.
- Sayago-Silva I, García-López F, Segovia-Cubero J. Epidemiology of heart failure in Spain over the last 20 years. Rev Esp Cardiol (Engl Ed). 2013;66 (8):649-56.
- Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: preventing disease and death worldwide. ESC Hear Fail. 2014;1(1):4-25.
- Pettifor JM. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr. 2004;80:1725S-9.
- Holick MF. Resurrection of vitamin D and rickets. J Clin Invest. 2006;116(8): 2062- 72.
- Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009;338(1):40-4.
- Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963-8.
- D’Amore C, Marsico F, Parente A, Paolillo S, De Martino F, Gargiulo P, et al. Vitamin D deficiency and clinical outcome in patients with chronic heart failure: A review. Nutr Metab Cardiovasc Dis. 2017;27(10):837-49.
- Norman AW. From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(2):491s-9s.
- Camici M, Galetta F, Franzoni F, Carpi A, Zangeneh F. Vitamin D and heart. Intern Emerg Med. 2013;8(Suppl 1):5-9.
- Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol. 2007;103(3-5):521-4.
- Green JJ, Robinson DA, Wilson GE, Simpson RU, Westfall MV. Calcitriol modulation of cardiac contractile performance via protein kinase C. J Mol Cell Cardiol. 2006;41(2):350-9.
- McMurray JJ, Packer M, Desay A, Gong J, Lefkowitz M. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2016;291-3.
- Bayes-Genis A, Morant-Talamante N, Lupón J. Neprilysin and natriuretic peptide regulation in heart failure. Curr Heart Fail Rep. 2016;13(4):151-7.
- Li YC, Kong J, Wei M, Chen Z, Liu SQ, Cao L. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest.
;110(2):229-38.
- Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta. 2010;411(17-18):1354-60.
- Forman JP, Williams JS, Fisher NDL. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension.
;55(5):1283-8.
- Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 2017;57(2):313-70.
- Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003;88(2):327-31.
- Kestenbaum B, Katz R, De Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol. 2011;58(14): 1433-41.
- Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N. Proinflammatory cytokines in heart failure: Double-edged swords. Heart Fail Rev. 2010;15(6):543-62.
- Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J. 1997; 61:657-64.
- Mora JR, Iwata M, Von Andrian UH. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat Rev Immunol. 2008;8(9):685-98.
- DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 Suppl):1689S-96S. [ Links ]
- Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003;2054-60.
- Gunja-Smith Z, Morales AR, Romanelli R, Woessner JF. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am J Pathol. 1996;148(5):1639-48.
- Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci. 2002;97(23):12746-5.
- Weber KT, Weglicki WB, Simpson RU. Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res.
;81(3):500-8.
- Paraguassu, Éber Coelho, et al. "Association of Bacterial Endocarditis and Buccomaxillofacial Surgery: Review of Current Medical Literature." OHDM-Oral Health and Dental Management 18 (2019).
- Akin F, Ayça B, Köse N, Duran M, Sarı M, Uysal OK, et al. Serum vitamin D levels are independently associated with severity of coronary artery disease. J Investig Med. 2016;60(6):869-73.
- Calistro, Lucas Cesar, et al. "Dental care in hypertense patients: systematic review." Brazilian Journal of Implantology and Health Sciences 1.6 (2019): 152-168.
- Molinari C, Uberti F, Grossini E, Carda S, Invernizzi M, Cisari C. 1α,25- dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem. 2011; 27(6):661-8.
- Grundmann M, Haidar M, Placzko S, Niendorf R, Darashchonak N, Hubel CA, et al. Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Physiol. 2012;303(9):954-62.
- Stach K, Kälsch AI, Nguyen XD, Elmas E, Kralev S, Lang S, et al. 1α,25- dihydroxyvitamin D 3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology. 2011;118(2):107-15.
- Al Mheid I, Quyyumi AA. Vitamin D and cardiovascular disease: controversy unresolved. J Am Coll Cardiol. 2017;70(1):89-100.
- Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999;56(2):383-92.
- Levin A, Bakris GL, Molitch M,Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int.
;71(1):31-8.
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18-28.
- Giustina A, Adler RA, Binkley N, Bouillon R, Ebeling PR, Lazaretti-Castro M, et al. Controversies in vitamin D: summary statement from an international conference. J Clin Endocrinol Metab. 2019;104(2):234-40.
- Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30.
- Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713-6.
- Holick MF. High Prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353-73.
- Ross AC, Manson JAE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-8.
- Glendenning P, Inderjeeth CA, Holick M. Measuring vitamin D. Clin Biochem. 2012;38(12):901-6.
- Glendenning P, Inderjeeth CA. Vitamin D: Methods of 25 hydroxyvitamin D analysis, targeting at risk populations and selecting thresholds of treatment. Clin Biochem. 2012;45(12):901-6.
- Kennel K, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85(8):752-8.
- Holick MF. NIH public vitamin D status: measurement, interpretation and clinical application. Ann Epidemiol. 2009;19(2):73-8.
- Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144:138-45.
- Holick MF, Chen TC. Vitamin D deficiency: a worldwide health problem. Am J Clin Nutr. 2008;87:1080-6.
- Groba Marco M, Mirallave Pescador A, González Rodríguez E, García Santana S, González Padilla E, Santana P S, et al. Factores relacionados con insuficiencia de vitamina D en estudiantes de Medicina de Gran Canaria. Rev Osteoporos Metab Miner. 2010;2:11-8.
- Marwaha RK, Tandon N, Reddy DRHK, Aggarwal R, Singh R, Sawhney RC, et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr. 2005; 82(2):477-82.
- Fuleihan GE-H, Nabulsi M, Choucair M, Salamoun M, Shahine CH, Kizirian A, et al. Hypovitaminosis D in healthy schoolchildren. Pediatrics. 2004;107 (4):e53-e53.
- McGrath J, Kimlin M, Saha S, Eyles D, Parisi A. Vitamin D insufficiency in south- east Queensland. Med J Austr. 2001;174; 150-151.
- Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008;102(11):1540-4.
- Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997;103(3):197-207.
- Zittermann A, Schulze Schleithoff S, Tenderich G, Berthold HK, Körfer R, Stehle
P. Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41(1):105-12.
- Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93(10):3927-35.
- Bansal N, Zelnick L, Robinson-Cohen C, Hoofnagle AN, Ix JH, Lima JA, et al. Serum parathyroid hormone and 25hydroxyvitamin D concentrations and risk of incident heart failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2014;3(6):1-15.
- Wannamethee GS, Welsh PW, Papacosta OP, Lennon L, Whincup PH, Sattar N. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Hear Fail. 2014;7(5):732-9.
- Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: The Tromso Study. Eur J Prev Cardiol. 2004;11(1):69-74.
- Zittermann A, Ernst JB. Calciotropic and phosphaturic hormones in heart failure. Nutr Metab Cardiovasc Dis. 2016;26(11):971-9.
- Zittermann A, Schleithoff SS, Koerfer R. Vitamin D insufficiency in congestive heart failure: Why and what to do about it? Heart Fail Rev. 2006;11(1):25-33.
OS AUTORES DECLARAM NÃO HAVER CONFLITOS DE INTERESSE / THE AUTHORS DECLARE NO CONFLICTS OF INTEREST
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Suzane Medeiros Bacelar, Irlan Fernandez Bacelaer, Salomão Barauna Alcolumbre